Amid speculation that the Aussie cannabis market is in the sights of global pharmaceutical companies, the big-wigs at Creso Pharma have announced a partnership with a WA-based group to import and sell products down under.
The partnership – with WA’s Health House International (HHI) – will see HHI importing products from Canadian cannabis companies through Creso. HHI will then distribute the products across Australia.
Meantime, another cannabis company Auscann Group Holdings today debuted on the ASX, reports Proactive Investors.
Creso initially listed on the ASX back in October, and saw its shares soar within its first day. See more on that here.
